KYMR
Price
$30.07
Change
-$0.70 (-2.27%)
Updated
May 9 closing price
Capitalization
1.96B
82 days until earnings call
RGLS
Price
$7.87
Change
+$0.02 (+0.25%)
Updated
May 9 closing price
Capitalization
544.53M
93 days until earnings call
Ad is loading...

KYMR vs RGLS

Header iconKYMR vs RGLS Comparison
Open Charts KYMR vs RGLSBanner chart's image
Kymera Therapeutics
Price$30.07
Change-$0.70 (-2.27%)
Volume$535.92K
Capitalization1.96B
Regulus Therapeutics
Price$7.87
Change+$0.02 (+0.25%)
Volume$1.65M
Capitalization544.53M
KYMR vs RGLS Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. RGLS commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and RGLS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (KYMR: $30.07 vs. RGLS: $7.87)
Brand notoriety: KYMR and RGLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 73% vs. RGLS: 70%
Market capitalization -- KYMR: $1.96B vs. RGLS: $544.53M
KYMR [@Biotechnology] is valued at $1.96B. RGLS’s [@Biotechnology] market capitalization is $544.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRGLS’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RGLS’s FA Score: 0 green, 5 red.
According to our system of comparison, RGLS is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while RGLS’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 5 bearish.
  • RGLS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RGLS is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -14.77% price change this week, while RGLS (@Biotechnology) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

RGLS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.96B) has a higher market cap than RGLS($545M). RGLS YTD gains are higher at: 398.101 vs. KYMR (-25.255). RGLS has higher annual earnings (EBITDA): -45.85M vs. KYMR (-216.24M). KYMR has more cash in the bank: 489M vs. RGLS (75.8M). RGLS has less debt than KYMR: RGLS (274K) vs KYMR (87.8M). KYMR has higher revenues than RGLS: KYMR (47.1M) vs RGLS (0).
KYMRRGLSKYMR / RGLS
Capitalization1.96B545M359%
EBITDA-216.24M-45.85M472%
Gain YTD-25.255398.101-6%
P/E RatioN/AN/A-
Revenue47.1M0-
Total Cash489M75.8M645%
Total Debt87.8M274K32,044%
FUNDAMENTALS RATINGS
RGLS: Fundamental Ratings
RGLS
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRRGLS
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 17 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFDSX18.390.02
+0.11%
Hartford Schroders US MidCap Opps R4
GSFTX33.12-0.01
-0.03%
Columbia Dividend Income Inst
NINDX57.18-0.03
-0.05%
Columbia Large Cap Index Inst
TGWTX13.00-0.04
-0.31%
Transamerica Large Growth I3
RYOAX47.31-0.97
-2.01%
Rydex Biotechnology H